All In MedTech

Device Trial Radar · NCT00227344

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation

Catheter Ablation for Cure of Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 129 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

129

Actual

Start

Dec 2004

Primary completion

Oct 2008

Study completion May 2009

Sponsor

Lead sponsor
Biosense Webster EMEAPublic (JNJ)
Sponsor type
Industry
First posted
Sep 28, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this prospective multicenter randomized study is to establish the effectiveness of treatment of persistent atrial fibrillation by encircling the pulmonary veins with radiofrequency (RF) ablation and creating additional lines of block with the aid of the NAVISTAR® THERMOCOOL® catheter in conjunction with the CARTO™ EP Navigation System. Effectiveness will be determined by comparing the chronic success of ablation therapy versus antiarrhythmic drug therapy, defined as the absence of persistent tachyarrhythmias during the first 24 months after a run-in phase of 2 months.

Conditions

  • Atrial Fibrillation

Interventions

  • RF ablationDevice

    Catheter ablation with NAVISTAR® THERMOCOOL® Catheter in conjunction with CARTO™ EP Navigation System

  • Antiarrhythmic drugsDrug

    Best antiarrhythmic drug according to local practice (amiodarone suggested) throughout the study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Absence of Persistent Atrial Tachyarrhythmias Relapse During the First 24 Months After the run-in Phase (2 Months).Time frame: within first 24 months after a 2-month run-in phase

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.